B细胞活动标志物与原发性干燥综合征不同疾病活动度域相关
研究纳入英国原发性干燥综合征登记队列553例患者和286例健康对照,检测游离轻链、BAFF和β2微球蛋白,发现三种标志物均与ESSDAI及ClinESSDAI总分相关,但关联的疾病活动度域不同,BAFF与周围神经系统域相关,β2M和游离轻链与皮肤、生物学和肾脏域相关。
要点
- BAFF、β2M和游离轻链在pSS患者中均高于健康对照,且均与ESSDAI和ClinESSDAI总分显著相关。
- BAFF与ESSDAI周围神经系统域相关,β2M和游离轻链与皮肤、生物学和肾脏域相关。
- 多变量分析显示BAFF、β2M及其交互作用是ESSDAI/ClinESSDAI的独立预测因素。
核心结论
- 所有标志物均与ESSDAI总分相关,但关联的疾病活动度域不同。
- 作者认为这些发现应促进在纵向研究中及与其他疾病活动度指标对照进一步研究这些标志物。
研究设计与样本
- 研究纳入英国原发性干燥综合征登记队列(UKPSSR)的553例pSS患者和286例健康对照,检测血清游离轻链(κ和λ)、BAFF和β2M。
- 计算Pearson相关系数分析患者临床特征,包括唾液流率、Schirmer试验、EULAR干燥综合征患者报告指数和血清IgG水平。
- 采用Poisson回归识别总ESSDAI和ClinESSDAI(验证的ESSDAI减去生物学域)评分及其各域的独立预测因素。
主要发现
- pSS患者中BAFF、β2M和游离轻链水平高于健康对照。
- 三种标志物均与ESSDAI和ClinESSDAI显著相关。
- BAFF与ESSDAI周围神经系统域相关,而β2M和游离轻链与皮肤、生物学和肾脏域相关。
- 多变量分析显示BAFF、β2M及其交互作用是ESSDAI/ClinESSDAI的独立预测因素。
- 游离轻链也与ESSDAI/ClinESSDAI相关,但非独立于血清IgG。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者在结论中提出这些发现应促进在纵向研究中及与其他疾病活动度指标对照进一步研究这些标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: B-cell activating factor (BAFF), β-2 microglobulin (β2M) and serum free light chains (FLCs) are elevated in primary SS (pSS) and associated with disease activity. We aimed to investigate their association with the individual disease activity domains of the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) in a large well-characterized pSS cohort. METHODS: Sera from pSS patients enrolled in the UK Primary Sjögren's Syndrome Registry (UKPSSR) (n = 553) and healthy controls (n = 286) were analysed for FLC (κ and λ), BAFF and β2 M. Pearson correlation coefficients were calculated for patient clinical characteristics, including salivary flow, Schirmer's test, EULAR Sjögren's Syndrome Patient Reported Index and serum IgG levels. Poisson regression was performed to identify independent predictors of total ESSDAI and ClinESSDAI (validated ESSDAI minus the biological domain) scores and their domains. RESULTS: Levels of BAFF, β2M and FLCs were higher in pSS patients compared to controls. All three biomarkers associated significantly with the ESSDAI and the ClinESSDAI. BAFF associated with the peripheral nervous system domain of the ESSDAI, whereas β2M and FLCs associated with the cutaneous, biological and renal domains. Multivariate analysis showed BAFF, β2M and their interaction to be independent predictors of ESSDAI/ClinESSDAI. FLCs were also shown to associate with the ESSDAI/ClinESSDAI but not independent of serum IgG. CONCLUSION: All biomarkers were associated with total ESSDAI scores but with differing domain associations. These findings should encourage further investigation of these biomarkers in longitudinal studies and against other disease activity measures.
引用
- James K, Chipeta C, Parker A, et al. B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome. Rheumatology (Oxford). 2018. PMID: 29608774. doi:10.1093/rheumatology/key063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。